Skip to content
Boost Up Blog – Lifestyle
Author:
Caribou Biosciences, Inc.
Caribou Biosciences Reports Third Quarter 2026 Financial Results
November 5, 2026
Caribou Biosciences Announces Presentations at the 2026 American Society of Hematology (ASH) Annual Meeting
November 4, 2026
Caribou Biosciences to Evaluate Strategic Alternatives
October 6, 2026
Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
August 13, 2026
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
June 29, 2026
Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting
June 11, 2026
Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026
June 11, 2026
Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference
May 27, 2026
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference
May 21, 2026
Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting
May 20, 2026